Evidence map›Paper›PMID 40251820›Full record

ArticleInternational wound journal2025

Clinical Efficacy of Ovine Forestomach Matrix and Collagen/Oxidised Regenerated Cellulose for the Treatment of Venous Leg Ulcers: A Retrospective Comparative Real-World Evidence Study.

Rebecca Aburn, Abigail E Chaffin, Brandon A Bosque, Christopher Frampton, Sandi G Dempsey, D Adam Young, Barnaby C H May, Gregory A Bohn, M Mark Melin

Abstract readComparative Study
In one paragraph

Article in International wound journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rebecca AburnHealthcare New Zealand, Richmond, New Zealand.ORCID https://orcid.org/0000-0003-0954-3004
Abigail E ChaffinDivision of Plastic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA.ORCID https://orcid.org/0000-0001-6446-7142
Brandon A BosqueAroa Biosurgery Limited, Auckland, New Zealand.ORCID https://orcid.org/0000-0001-6563-8775
Christopher FramptonDepartment of Psychological Medicine (Christchurch), Otago University, Christchurch, New Zealand.
Sandi G DempseyAroa Biosurgery Limited, Auckland, New Zealand.ORCID https://orcid.org/0000-0002-2616-0411
D Adam YoungAroa Biosurgery Limited, Auckland, New Zealand.ORCID https://orcid.org/0009-0003-2868-5881
Barnaby C H MayAroa Biosurgery Limited, Auckland, New Zealand.ORCID https://orcid.org/0000-0001-9855-018X
Gregory A BohnThe American Professional Wound Care Association (APWCA), American Board of Wound Healing, Milwaukee, Wisconsin, USA.ORCID https://orcid.org/0000-0003-3706-9178
M Mark MelinGonda Vascular Center, Wound Clinic, Mayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-1368-0426

Funding

Aroa Biosurgery Limited (Auckland, NZ)
6 · The paper itself

Abstract

Venous leg ulcers (VLUs) are traditionally managed with standard-of-care dressings, compression and appropriate adjunctive venous interventions for pathologic venous reflux. Due to pathophysiological complexity and underlying patient comorbidities, conducting randomised controlled trials to evaluate the comparative efficacy of advanced treatment modalities is difficult, as many patients would likely be excluded. This retrospective, pragmatic, real-world evidence (RWE) study compared the healing outcomes of VLUs treated with either ovine forestomach matrix (OFM) (n = 312) or collagen/oxidised regenerated cellulose (ORC) (n = 239) in outpatient wound care centres. Unlike restrictive randomised controlled trials, minimal inclusion and exclusion criteria were applied to create two treatment cohorts that reflected the general VLU population. The incidence (%) of closure was greater in OFM-treated VLUs at 12, 24 and 36 weeks, and this difference was significant at 24 and 36 weeks compared to collagen/ORC. Median time to wound closure was significantly faster (p = 0.045) in the OFM cohort (11.1 ± 0.6 weeks) compared to the collagen/ORC group (12.3 ± 1.0 weeks). Cox proportional hazards analysis demonstrated that OFM-treated VLUs had a significantly greater probability of healing (up to ~40%). This RWE comparative efficacy study further substantiates the clinical benefit of OFM in the treatment of chronic wounds, such as VLU, in a real-world patient cohort.

Indexed as

Biological DressingsCellulose, OxidizedCollagenVaricose UlcerWound HealingAdultAgedAged, 80 and overAnimalsFemaleHumansLeg UlcerMaleMiddle AgedRetrospective StudiesSheepCellulose, OxidizedCollagencollagen/ORCovine forestomach matrixreal‐world evidencevenous leg ulcervenous stasis ulcer

Identifiers

PMID40251820
PMCPMC12008172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.